News about Biotechnology

ABL Medical Developing Anti-Microbial Blue Light Fiber Technology

ABL Medical has now demonstrated the potential for blue light fiber-optic technology to combat microbial infections.

Biotechnology | 10/02/2024 | By Manvi |  539

MicrofluidX Announces Joint Research Project with Immatics for Automated End-to-End Bioprocessing for TCR-T Therapies

MicrofluidX announces a joint research project with Immatics to combine Immatics’ manufacturing of TCR-T cells with MicrofluidX’s innovative new platform, the Cyto Engine™.

Biotechnology | 03/05/2023 | By Manvi |  856

Novartis to invest $300 M in biologics manufacturing and development operations

The company plans to establish a biologics hub at its Basel, Switzerland campus

Biotechnology | 14/09/2022 | By Sudeep Soparkar |  780

Astellas plans to open biotech campus in South San Francisco

Astellas will invest approximately $70 million to create the new state-of-the-art facility, which will provide lab and co-working spaces to accommodate future growth

Biotechnology | 22/07/2022 | By Sudeep Soparkar |  1312

Merck unveils microbiology application lab in Jigani, Bengaluru

Supports capability built-up in microbial quality control in Pharma, and biopharma industry Merck invests €200,000 in the infrastructure of the new lab at Jigani

Biotechnology | 21/07/2022 | By Sudeep Soparkar |  1254

KBI Biopharma, Selexis open expanded facility in Geneva, Switzerland

The ~94,000 square-foot facility will house new laboratories to support Selexis’ unique technical cell line workflows and KBI’s process development and cGMP manufacturing

Biotechnology | 11/07/2022 | By Sudeep Soparkar |  973

Two ImmunoINSIGHTS contracts signed by Oncimmune

Oncimmune Holdings announces the signing of two new ImmunoINSIGHTS commercial contracts.

Biotechnology | 15/04/2022 | By Sudeep Soparkar |  849

Global diseases treatment with mRNA to be researched by Moderna and IAVI together

Moderna and IAVI, a nonprofit scientific research organization, are teaming up to use mRNA to develop new therapies for a range of diseases like HIV / AIDS, Tuberculosis, anti-microbial-resistant enteric infection and COVID-19.

Biotechnology | 12/04/2022 | By Sudeep Soparkar |  792

The AI-designed protective betacoronavirus vaccine to be developed jointly by CEPI and Japan?s NEC Group

CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation declared the most recent subsidizing grant under its US$ 200 million program to propel the improvement of antibodies that give wide assurance against SARS-CoV-2 variations and other betacoronaviruses.

Biotechnology | 09/04/2022 | By Sudeep Soparkar |  452

Collaboration between ICMR and Pharma companies to develop Dengue vaccine

With the rise in dengue cases across the country, the Indian Council of Medical Research (ICMR) has embarked on an initiative aiming to facilitate development of dengue vaccine. Vaccine manufacturer and pharma companies who have developed or have license of tetravalent dengue vaccine candidate and have successfully completed its phase I and phase II

Biotechnology | 07/03/2022 | By Darshana |  655